Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into the drugmaker's promotional speakers program for HIV drugs. The Foster City,

We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care and personalized treatment.

MadameNoire breaks down three common myths about HIV that persist today. Together, let's uncover the truth behind the stigma.

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten to undermine progress.

Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential resolution of an eight-year case surrounding its promotional speaker program for HIV drugs.

The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the help of the US government's AIDS fund,

USAID's withdrawal of funding significantly impacts LGBTQ+ advocacy and HIV services in the Philippines. Organizations like LoveYourself, reliant on foreign aid, are urging local institutions to step up.

BANGOR, Maine (WABI) - The Maine CDC has announced there are now 21 confirmed cases of HIV in Penobscot County. During a Bangor Government Operations meeting Monday Health Director Jennifer Gunderman discussed recent findings. She said one of the factors leading to the increase in reported cases is an increase in testing.

Understanding how ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus.